Opens in a new window
A phase II trial shows that the risk of cancer recurrence as reflected by circulating tumour DNA can guide a risk-adaptive treatment strategy that improves participants’ survival compared with the current standard of care. Our biological insights can be translated into clinical decision-making — challenging the conventional fixed-course, therapeutic approach.，详情可参考新收录的资料
。关于这个话题，新收录的资料提供了深入分析
Early trials of the drug VIR-5500 showed it shrinking tumours in some patients
走进全国政协十四届四次会议农业界别小组会议会场，现场未摆放鲜花绿植，茶杯等用具简单统一，布置简约朴实。会议室里，33位全国政协委员围坐，讨论紧扣主题。，详情可参考新收录的资料